60 DEGREES PHARMACEUTICALS, INC.: cash and cash equivalents

What this measure means

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Exact concept: us-gaap:CashAndCashEquivalentsAtCarryingValue. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2023-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• 60 DEGREES PHARMACEUTICALS, INC.: total assets
• 60 DEGREES PHARMACEUTICALS, INC.: total liabilities
• 60 DEGREES PHARMACEUTICALS, INC.: stockholders equity
• 60 DEGREES PHARMACEUTICALS, INC.: net income or loss
• 60 DEGREES PHARMACEUTICALS, INC.: operating cash flow
• 60 DEGREES PHARMACEUTICALS, INC.: capital expenditure payments
• 60 DEGREES PHARMACEUTICALS, INC.: revenue
• 60 DEGREES PHARMACEUTICALS, INC.: financing cash flow
• 60 DEGREES PHARMACEUTICALS, INC.: investing cash flow
• 60 DEGREES PHARMACEUTICALS, INC.: retained earnings or deficit
• 60 DEGREES PHARMACEUTICALS, INC.: basic weighted-average shares
• 60 DEGREES PHARMACEUTICALS, INC.: diluted weighted-average shares
• 60 DEGREES PHARMACEUTICALS, INC.: basic earnings per share
• 60 DEGREES PHARMACEUTICALS, INC.: diluted earnings per share
• 60 DEGREES PHARMACEUTICALS, INC.: income tax expense or benefit
• 60 DEGREES PHARMACEUTICALS, INC.: net property, plant and equipment
• 60 DEGREES PHARMACEUTICALS, INC.: operating income or loss
• 60 DEGREES PHARMACEUTICALS, INC.: current assets
• 60 DEGREES PHARMACEUTICALS, INC.: current liabilities
• 60 DEGREES PHARMACEUTICALS, INC.: net current accounts receivable
• 60 DEGREES PHARMACEUTICALS, INC.: operating expenses
• 60 DEGREES PHARMACEUTICALS, INC.: net inventory
• 60 DEGREES PHARMACEUTICALS, INC.: gross profit
• 60 DEGREES PHARMACEUTICALS, INC.: cost of revenue
• 60 DEGREES PHARMACEUTICALS, INC.: research and development expense

Inspect the source

Entity

60 DEGREES PHARMACEUTICALS, INC. / CIK 0001946563

Captured

2026-09-21T17:41:45.368Z

SEC response SHA-256

b95fff66e7a953f292c25a6ce30bc53c9746adb7dec7916bb5971972be8b9ae4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001946563.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))